Suppr超能文献

识别感染丙型肝炎的既往注射吸毒者:基于一般实践的病例发现干预措施的评估。

Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention.

机构信息

Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, UK.

出版信息

J Public Health (Oxf). 2012 Mar;34(1):14-23. doi: 10.1093/pubmed/fdr097. Epub 2011 Dec 2.

Abstract

BACKGROUND

In Scotland, a general practice-based case-finding initiative, to diagnose and refer hepatitis C virus (HCV) chronically infected former injecting drug users (IDUs), was evaluated.

METHODS

Testing was offered in eight Glasgow general practices in areas of high deprivation and high HCV and IDU prevalence to attendees aged 30-54 years with a history of IDU. Test uptake and diagnosis rates were compared with those in eight demographically similar control practices.

RESULTS

Of 422 eligible intervention practice attendees, 218 (52%) were offered an HCV test and, of these, 121 (56%) accepted. Poor venous access in 13 individuals prevented testing. Of 105 tested, 70% (74/105) were antibody positive of which 58% (43/74) were RNA positive by PCR. Of 43 chronically infected individuals identified in intervention practices, 22 (51%) had attended specialist care within 30 months of the study, while 9 (21%) had defaulted. In control practices, 8 (22%) of 36 individuals tested were antibody positive. Test uptake and case yield were approximately 3 and 10 times higher in intervention compared with control practices, respectively.

CONCLUSIONS

Targeted case-finding in primary care demonstrated higher test uptake and diagnosis rates; however, to optimize diagnosis and referral of chronically infected individuals, alternative means of testing (e.g. dried blood spots) and retention in specialist care (e.g. outreach services) must be explored.

摘要

背景

在苏格兰,开展了一项基于全科医生的病例发现计划,旨在诊断和转介慢性感染丙型肝炎病毒(HCV)的前注射吸毒者(IDU)。

方法

在 8 家位于贫困和 HCV 及 IDU 流行率较高地区的格拉斯哥全科医生诊所,向年龄在 30-54 岁、有 IDU 史的就诊者提供检测。比较了检测的参与率和诊断率与 8 家在人口统计学上相似的对照诊所的情况。

结果

在 422 名符合条件的干预实践就诊者中,218 名(52%)被提供了 HCV 检测,其中 121 名(56%)接受了检测。13 人静脉穿刺困难,无法进行检测。在 105 名接受检测者中,70%(74/105)抗体阳性,其中 58%(43/74)PCR 检测 RNA 阳性。在干预实践中确定的 43 名慢性感染个体中,22 名(51%)在研究后 30 个月内接受了专科治疗,而 9 名(21%)失访。在对照诊所中,36 名接受检测者中有 8 名(22%)抗体阳性。与对照实践相比,干预实践的检测参与率和病例检出率分别高出约 3 倍和 10 倍。

结论

在初级保健中进行有针对性的病例发现可提高检测参与率和诊断率;然而,为了优化慢性感染个体的诊断和转介,必须探索替代检测方法(如干血斑)和保持在专科治疗中的联系(如外展服务)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验